Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment.
about
Dyskerin localizes to the mitotic apparatus and is required for orderly mitosis in human cellsEffects of protein extract from head-foot tissue of Oncomelania hupensis on the growth and gene expression of mother sporocysts of Schistosoma japonicum.DNA damage responses and oxidative stress in dyskeratosis congenita.Expression of the genetic suppressor element 24.2 (GSE24.2) decreases DNA damage and oxidative stress in X-linked dyskeratosis congenita cells.GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomerase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell Senescence in Dyskerin Mutant CellsRobust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita CellsCell autonomous and nonautonomous mechanisms drive hematopoietic stem/progenitor cell loss in the absence of DNA repair.CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging.The role of telomere shortening in somatic stem cells and tissue aging: lessons from telomerase model systems.Telomere shortening and Alzheimer's disease.DNA-damage response in hematopoietic stem cells: an evolutionary trade-off between blood regeneration and leukemia suppression.Targeted cargo delivery in senescent cells using capped mesoporous silica nanoparticles.Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shorteningDelay in oocyte aging in mice by the antioxidant N-acetyl-L-cysteine (NAC).Redox-dependent BMI1 activity drives in vivo adult cardiac progenitor cell differentiation.
P2860
Q27301721-D2083E76-1DB1-47F5-B8AF-D598FF69472AQ33975021-C79B5204-4B28-4F69-AB20-21DCBB862023Q35016987-8C1C4140-0F87-4C50-A668-403B7D9778C5Q35200061-16638D8F-E0A2-40BD-9E47-00889CCC1745Q35842203-44C69869-E725-4DBD-A940-08D94F539AAEQ35918178-0696DCA2-A63E-4EC4-A2BD-6E3A8D55D676Q36640300-4AD122CC-F281-430D-A2EB-AC68E901123AQ37256234-C9F071FD-FE27-4695-B165-25521691E929Q38035437-07C8949E-EC43-4E97-B55D-816D1D10185BQ38060615-265E1265-0B0E-42D9-A846-86FD637748B9Q39196083-487EAF72-261D-4AD5-9E47-397464C30C1EQ39274524-A0663008-AE7A-4E5F-8DA6-BB5469B4B882Q42660517-3AA35FCA-9387-4526-A9BB-3A53370E181DQ44583610-BC2A5B27-670F-4A6E-B756-653AA08491CFQ50093679-726C5F0F-7390-416D-8A3C-6B9E8C0A3579
P2860
Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Accelerated hematopoietic stem ...... onds to antioxidant treatment.
@ast
Accelerated hematopoietic stem ...... onds to antioxidant treatment.
@en
type
label
Accelerated hematopoietic stem ...... onds to antioxidant treatment.
@ast
Accelerated hematopoietic stem ...... onds to antioxidant treatment.
@en
prefLabel
Accelerated hematopoietic stem ...... onds to antioxidant treatment.
@ast
Accelerated hematopoietic stem ...... onds to antioxidant treatment.
@en
P2093
P2860
P1433
P1476
Accelerated hematopoietic stem ...... onds to antioxidant treatment.
@en
P2093
Bai-Wei Gu
Jian-Meng Fan
Monica Bessler
Philip J Mason
P2860
P304
P356
10.1111/J.1474-9726.2011.00674.X
P577
2011-02-21T00:00:00Z